72 related articles for article (PubMed ID: 15980874)
1. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
Caballero R; Valenzuela C; Longobardo M; Tamargo J; Delpón E
Br J Pharmacol; 1999 Nov; 128(5):1071-81. PubMed ID: 10556945
[TBL] [Abstract][Full Text] [Related]
2. Exenatide reduces atrial fibrillation susceptibility by inhibiting hKv1.5 and hNav1.5 channels.
Zhou Q; Hao G; Xie W; Chen B; Lu W; Wang G; Zhong R; Chen J; Ye J; Shen J; Cao P
J Biol Chem; 2024 May; 300(5):107294. PubMed ID: 38636665
[TBL] [Abstract][Full Text] [Related]
3. A key role for peroxynitrite-mediated inhibition of cardiac ERG (Kv11.1) K
Al-Owais MM; Hettiarachchi NT; Kirton HM; Hardy ME; Boyle JP; Scragg JL; Steele DS; Peers C
FASEB J; 2017 Nov; 31(11):4845-4854. PubMed ID: 28743763
[TBL] [Abstract][Full Text] [Related]
4. A triple cysteine motif as major determinant of the modulation of neuronal K
Ray S; Stampf JL; Kudlacek O; Yang JW; Schicker KW; Graf Y; Losgott T; Boehm S; Salzer I
Br J Pharmacol; 2024 Apr; ():. PubMed ID: 38657956
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and Uncertainty Analysis of Two Human Atrial Cardiac Cell Models Using Gaussian Process Emulators.
Coveney S; Clayton RH
Front Physiol; 2020; 11():364. PubMed ID: 32390867
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model.
Reisqs JB; Moreau A; Sleiman Y; Charrabi A; Delinière A; Bessière F; Gardey K; Richard S; Chevalier P
J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836569
[TBL] [Abstract][Full Text] [Related]
7. Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity.
Carpenter MA; Kemp MG
JID Innov; 2021 Sep; 1(3):100023. PubMed ID: 34909723
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis.
Andrade-Neto VV; da Silva Pacheco J; Inácio JD; Almeida-Amaral EE; Torres-Santos EC; Cunha-Junior EF
Front Pharmacol; 2021; 12():636265. PubMed ID: 33927619
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Beat-to-Beat Variations of P-Waves Morphologies in AF Patients During Sinus Rhythm: A Scoping Review of the Atrial Simulation Studies.
Filos D; Tachmatzidis D; Maglaveras N; Vassilikos V; Chouvarda I
Front Physiol; 2019; 10():742. PubMed ID: 31275161
[TBL] [Abstract][Full Text] [Related]
10. Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist.
Iqbal J; Andrew R; Cruden NL; Kenyon CJ; Hughes KA; Newby DE; Hadoke PW; Walker BR
J Clin Endocrinol Metab; 2014 Mar; 99(3):915-22. PubMed ID: 24423282
[TBL] [Abstract][Full Text] [Related]
11. Female pattern alopecia: current perspectives.
Levy LL; Emer JJ
Int J Womens Health; 2013 Aug; 5():541-56. PubMed ID: 24039457
[TBL] [Abstract][Full Text] [Related]
12. Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.
Jeong I; Yoon SH; Hahn SJ
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jul; 385(7):707-16. PubMed ID: 22538641
[TBL] [Abstract][Full Text] [Related]
13. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
Jeong I; Choi BH; Hahn SJ
Pflugers Arch; 2010 Oct; 460(5):851-62. PubMed ID: 20734202
[TBL] [Abstract][Full Text] [Related]
14. The negative inotropic action of canrenone is mediated by L-type calcium current blockade and reduced intracellular calcium transients.
Costa AR; Torres LB; Medei E; Ricardo RA; França JP; Smaili S; Nascimento JH; Oshiro ME; Bassani JW; Ferreira AT; Tucci PJ
Br J Pharmacol; 2009 Sep; 158(2):580-7. PubMed ID: 19663883
[TBL] [Abstract][Full Text] [Related]
15. Non-antiarrhythmic medications for atrial fibrillation: from bench to clinical practice.
Guglin M; Garcia M; Yarnoz MJ; Curtis AB
J Interv Card Electrophysiol; 2008 Aug; 22(2):119-28. PubMed ID: 18317915
[TBL] [Abstract][Full Text] [Related]
16. Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis.
Mancilla-Simbro C; López A; Martinez-Morales E; Soto-Perez-de-Celis E; Millan-PerezPeña L; Tsushima R; Salinas-Stefanon EM
Br J Pharmacol; 2008 Feb; 153(3):448-58. PubMed ID: 18037918
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.
Gómez R; Núñez L; Caballero R; Vaquero M; Tamargo J; Delpón E
Br J Pharmacol; 2005 Sep; 146(1):146-61. PubMed ID: 15980874
[TBL] [Abstract][Full Text] [Related]
18. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
